Patents by Inventor David Hasker
David Hasker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220287563Abstract: Embodiments related to a self-administered, behavior modification program facilitated through a structured tailoring method and system thereof which accelerates and enhances the internalization process of the individual, and which provides help when the individual begins to fail in adhering or continuing with the behavior modification are disclosed. Program instructions that when executed by a processor causes a processor to initiate automatically a schedule of events of a structured tailoring procedure upon entry criteria being met at some unknown time, provide intervention according to the intervention preferences when the adherence criteria for one of the events has not been met, and end automatically the structured collection procedure upon exit criteria being met at some unknown time.Type: ApplicationFiled: June 2, 2022Publication date: September 15, 2022Applicant: Roche Diabetes Care, Inc.Inventors: Daniel Wong, David Hasker, Glenn Brassington, Stefan Weinert, Abhishek S. Soni, Alan Greenburg, Paul J. Galley, Ulrich Porsch, Robert E. Reinke, Marco De Polo
-
Patent number: 11382507Abstract: Embodiments related to a self-administered, behavior modification program facilitated through a structured tailoring method and system thereof which accelerates and enhances the internalization process of the individual, and which provides help when the individual begins to fail in adhering or continuing with the behavior modification are disclosed. Program instructions that when executed by a processor causes a processor to initiate automatically a schedule of events of a structured tailoring procedure upon entry criteria being met at some unknown time, provide intervention according to the intervention preferences when the adherence criteria for one of the events has not been met, and end automatically the structured collection procedure upon exit criteria being met at some unknown time.Type: GrantFiled: September 23, 2019Date of Patent: July 12, 2022Assignee: Roche Diabetes Care, Inc.Inventors: Daniel Wong, David Hasker, Glenn Brassington, Stefan Weinert, Abhishek S. Soni, Alan Greenburg, Paul J. Galley, Ulrich Porsch, Robert E. Reinke, Marco De Polo
-
Publication number: 20200015680Abstract: Embodiments related to a self-administered, behavior modification program facilitated through a structured tailoring method and system thereof which accelerates and enhances the internalization process of the individual, and which provides help when the individual begins to fail in adhering or continuing with the behavior modification are disclosed. Program instructions that when executed by a processor causes a processor to initiate automatically a schedule of events of a structured tailoring procedure upon entry criteria being met at some unknown time, provide intervention according to the intervention preferences when the adherence criteria for one of the events has not been met, and end automatically the structured collection procedure upon exit criteria being met at some unknown time.Type: ApplicationFiled: September 23, 2019Publication date: January 16, 2020Applicant: Roche Diabetes Care, Inc.Inventors: Daniel Wong, David Hasker, Glenn Brassington, Stefan Weinert, Abhishek S. Soni, Alan Greenburg, Paul J. Galley, Ulrich Porsch, Robert E. Reinke, Marco De Polo
-
Patent number: 10522247Abstract: Embodiments of methods of assessing a diabetes treatment protocol comprise determining a protocol complexity level corresponding to a degree of difficulty of completing the diabetes treatment protocol by utilizing the processor, determining a patient proficiency level corresponding to a skill set of the patient in conducting the diabetes treatment protocol by utilizing the processor, comparing the protocol complexity level to the patient proficiency level via the processor, and providing an output based on the comparison.Type: GrantFiled: September 20, 2016Date of Patent: December 31, 2019Inventors: Paul J. Galley, Stefan Weinert, David Hasker, Ulrich Porsch
-
Patent number: 10456036Abstract: Embodiments related to a self-administered, behavior modification program facilitated through a structured tailoring method and system thereof which accelerates and enhances the internalization process of the individual, and which provides help when the individual begins to fail in adhering or continuing with the behavior modification are disclosed. Program instructions that when executed by a processor causes a processor to initiate automatically a schedule of events of a structured tailoring procedure upon entry criteria being met at some unknown time, provide intervention according to the intervention preferences when the adherence criteria for one of the events has not been met, and end automatically the structured collection procedure upon exit criteria being met at some unknown time.Type: GrantFiled: June 18, 2010Date of Patent: October 29, 2019Assignee: Roche Diabetes Care, Inc.Inventors: Daniel Wong, David Hasker, Glenn Brassington, Stefan Weinert, Abhishek S. Soni, Alan Greenburg, Paul J. Galley, Ulrich Porsch, Robert E. Reinke, Marco De Polo
-
Publication number: 20170011176Abstract: Embodiments of methods of assessing a diabetes treatment protocol comprise determining a protocol complexity level corresponding to a degree of difficulty of completing the diabetes treatment protocol by utilizing the processor, determining a patient proficiency level corresponding to a skill set of the patient in conducting the diabetes treatment protocol by utilizing the processor, comparing the protocol complexity level to the patient proficiency level via the processor, and providing an output based on the comparison.Type: ApplicationFiled: September 20, 2016Publication date: January 12, 2017Inventors: Paul J. Galley, Stefan Weinert, David Hasker, Ulrich Porsch
-
Patent number: 8369918Abstract: Body fluid sampling device comprising a sampling element having a fluid pathway (11) for receiving body fluid, at least a portion of the fluid pathway is open to the environment and further comprising a fluid receiving means (40) being spaced from the fluid pathway so that fluid in the pathway will not contact the fluid receiving means initially. The fluid receiving means has two or more test zones (45) for performing analytical reactions. Fluid from the channel is contacted with the fluid receiving means either by bringing the fluid receiving means and the fluid into mechanical contact or by electrically transporting fluid from the channel onto the fluid receiving means.Type: GrantFiled: June 23, 2011Date of Patent: February 5, 2013Assignee: Roche Diagnostics Operations, Inc.Inventors: Irio G. Calasso, Patrick Griss, Emad Sarofim, Rainer Jaeggi, Uwe Kraemer, David Hasker, Volker Zimmer
-
Publication number: 20120173151Abstract: Embodiments of methods of assessing a diabetes treatment protocol comprise determining a protocol complexity level corresponding to a degree of difficulty of completing the diabetes treatment protocol by utilizing the processor, determining a patient proficiency level corresponding to a skill set of the patient in conducting the diabetes treatment protocol by utilizing the processor, comparing the protocol complexity level to the patient proficiency level via the processor, and providing an output based on the comparison.Type: ApplicationFiled: December 29, 2010Publication date: July 5, 2012Applicant: Roche Diagnostics Operations, Inc.Inventors: Paul J. Galley, Stefan Weinert, David Hasker, Ulrich Porsch
-
Patent number: 8000762Abstract: Body fluid sampling device comprising a sampling element having a fluid pathway (11) for receiving body fluid, at least a portion of the fluid pathway is open to the environment and further comprising a fluid receiving means (40) being spaced from the fluid pathway so that fluid in the pathway will not contact the fluid receiving means initially. The fluid receiving means has two or more test zones (45) for performing analytical reactions. Fluid from the channel is contacted with the fluid receiving means either by bringing the fluid receiving means and the fluid into mechanical contact or by electrically transporting fluid from the channel onto the fluid receiving means.Type: GrantFiled: August 31, 2006Date of Patent: August 16, 2011Assignee: Roche Diagnostics Operations, Inc.Inventors: Irio G. Calasso, Patrick Griss, Emad Sarofim, Rainer Jaeggi, Uwe Kraemer, David Hasker, Volker Zimmer
-
Publication number: 20110145747Abstract: Embodiments related to a self-administered, behavior modification program facilitated through a structured tailoring method and system thereof which accelerates and enhances the internalization process of the individual, and which provides help when the individual begins to fail in adhering or continuing with the behavior modification are disclosed. Program instructions that when executed by a processor causes a processor to initiate automatically a schedule of events of a structured tailoring procedure upon entry criteria being met at some unknown time, provide intervention according to the intervention preferences when the adherence criteria for one of the events has not been met, and end automatically the structured collection procedure upon exit criteria being met at some unknown time.Type: ApplicationFiled: June 18, 2010Publication date: June 16, 2011Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.Inventors: Daniel Wong, David Hasker, Glenn Brassington, Stefan Weinert, Abhishek S. Soni, Alan Greenburg, Paul J. Galley, Ulrich Porsch, Robert E. Reinke